Researchers at Fudan University, Shanghai, speed up target identification for non-small lung cancer therapy

Dr CHEN Hai-Quan and colleagues at Fudan University tumor hospital developed a real-time quantitative ALK fusion detection which within 90 min indicates if Crizotinib therapy, targeting this gene, is indicated.

Science and Technology Daily, Sept. 24, 2012